Abiomed Inc (ABMD.O)
ABMD.O on Consolidated Issue listed on NASDAQ Global Market
8.16USD
18 Dec 2009
8.16USD
18 Dec 2009
Price Change (% chg)
$0.06 (+0.74%)
$0.06 (+0.74%)
Prev Close
$8.10
$8.10
Open
$8.18
$8.18
Day's High
$8.28
$8.28
Day's Low
$8.07
$8.07
Volume
352,828
352,828
Avg. Vol
252,665
252,665
52-wk High
$17.31
$17.31
52-wk Low
$4.67
$4.67
About
Abiomed Inc. is a provider of medical devices in circulatory support that offers a continuum of care in heart recovery to heart failure patients. The Company’s products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. Its products can be used... (more)
Overall
| Beta: | 0.93 |
| Market Cap (Mil.): | $303.63 |
| Shares Outstanding (Mil.): | 37.49 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| ABMD.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 5.84 | 4.61 |
| EPS (TTM): | 26.20 | -- | -- |
| ROI: | -25.35 | 1.13 | 2.83 |
| ROE: | -26.18 | 1.67 | 3.59 |
US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1858 GMT
Following is a summary of research actions on non-S&P 500 companies reported
US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1726 GMT
Following is a summary of research actions on non-S&P 500 companies reported
US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1624 GMT
Following is a summary of research actions on non-S&P 500 companies reported
US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1536 GMT
Following is a summary of research actions on non-S&P 500 companies reported
US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1501 GMT
Following is a summary of research actions on non-S&P 500 companies reported
US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1243 GMT
Following is a summary of research actions on non-S&P 500 companies reported
US RESEARCH SUMMARY-Non-S&P 500 Feb 6 1205 GMT
Following is a summary of research actions on non-S&P 500 companies reported
UPDATE 1-Abiomed Q3 loss narrows; sees FY rev at low end
Feb 5 (Reuters) - Heart pump maker Abiomed Inc reported a narrower quarter loss mainly on strong revenue from its Impella catheter pumps, and forecast fiscal 2009 revenue at the lower end of its previous outlook.
US RESEARCH SUMMARY-Non-S&P 500 Nov 11 1650 GMT
Following is a summary of research actions on non-S&P 500
INTERVIEW-Abiomed eyes $2 bln opportunity in heart pumps
* Sees rapid market adoption of device since June launch
Competitors
| Price | Change | |
|---|---|---|
| Datascope Corporation (DSCP.OQ) | -- | -- |
| Teleflex Incorporated (TFX.N) | $53.21 | -0.07 |
| Thoratec Corporation (THOR.OQ) | $26.82 | -0.38 |
| HeartWare Limited (HTW.AX) | -- | -- |
| MicroMed Cardiovascular, Inc. (MMCO.PK) | $6,400.00 | 0.00 |
| Ventracor Limited (VCR.AX) | -- | -- |





Earnings vs
Estimates